Pavonine Co Ltd (177830) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Pavonine Co Ltd stock KRW 6,378, price KRW 2,135, upside +198.8%, quality 42 out of 100. Rating: strongly undervalued. Calculated from audited financials with 12 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
60‑month range 2,040 KRW – 6,202 KRW · fair‑value band 4,510 KRW – 9,083 KRW · the 2,135 KRW price screens below the 6,378 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 5, 2026.
Follow Pavonine Co in your weekly email
Every Wednesday you see whether Pavonine Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Pavonine Co., Ltd. manufactures and sells TVs, medical devices, industrial equipment, and household appliances in South Korea and rest of Asia.
Show moreShow less
The company offers TV appearance products and signage, such as the terrace external TV, digital signage, LED electric bulletin boards, electronic blackboards, curved game monitors, and kiosks.
It also offers metal fittings and structures for medical devices, such as x-rays, ultrasonics, ventilators, and chest x-rays equipment.
In addition, the company offers household appliances, such as doors, wine cellers, door in door refrigerators, stainless dishwashers, monogram bin and trims, café handle series, over the range, and refrigerator rotating bins.
Further, it provides industrial equipment, including roof cross bars for vehicles, kimchi cases, wall ovens, and dimchaes. The company was formerly known as EO Precision Industry Co., Ltd. and changed its name to Pavonine Co., Ltd. in December 2002.
Pavonine Co., Ltd. was founded in 1997 and is headquartered in Incheon, South Korea.
Stock analysis
Pavonine Co Ltd (177830) currently trades at 2,135 KRW, while our model-based Fair Value estimate is 6,378 KRW, implying the stock looks roughly 67% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 7,838 KRW per share, and 9 of the 12 models we run sit above the 2,135 KRW price.
Bear case: the Earnings-Based group reads lowest at 1,739 KRW, and 3 of the 12 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 4,510 KRW (bear) to 9,083 KRW (bull), the price of 2,135 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Technology sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Pavonine Co Ltd reported revenue of 133B KRW in FY2025 versus 126B KRW in FY2021, a compound +1.2%/yr. Reported net income was −3.7B KRW in FY2025.
Key figures
Market cap 24.3B KRW (≈ $17.9M) Micro · P/S ratio 0.17 · EPS (TTM) −354.48 KRW · Dividend yield 3.7% · Net margin −2.9% · Return on equity −5.8% · Return on assets (EBIT) 4.5% (5-year average) · Operating margin 0.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 11 out of 100 (low confidence).
What moves the price
The share trades about 31% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −7% fair-value upside, at 199%, 177830 screens cheaper than that median.
Fair Value models
Bear4,510 KRWFair Value 6,378 KRWBull9,083 KRW
Price 2,135 KRW · Upside +198.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.20/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−0.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.3%
Start year 2020 (pandemic). Over 10 years: +9.9% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
5.3% (2020) → 1.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+14.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +12.4% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 653 stocks
Beats the industry median on 8/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score42 · Bottom 25%
Fair Value upside+198.8% · Top 25%
Profitability
Return on assets−2.4% · Bottom 25%
Net margin (12 months)−2.9% · Bottom 25%
Operating margin (12 months)0.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)14.0% · Above median
Dividend yield (12 months)3.7% · Top 25%
Balance sheet
Debt / equity0.05× · Below median
Valuation Multiplesvs Electronic Components median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Pavonine Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/177830
Frequently asked questions
Is Pavonine Co Ltd (177830) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of 6,378 KRW versus a price of 2,135 KRW, about +199% upside (undervalued).
What is the fair value of 177830?
Our model-based fair value for Pavonine Co Ltd is 6,378 KRW (as of Nov 5, 2026), built from audited fundamentals. The current price: 2,135 KRW.
What is the quality score of 177830?
Pavonine Co Ltd has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Pavonine Co Ltd (177830)?
Our model-based price target is the fair value of 6,378 KRW (as of Nov 5, 2026) from 12 valuation models. Cautious scenario 4,510 KRW, optimistic scenario 9,083 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Pavonine Co Ltd stock forecast for 2026?
Our models put fair value at 6,378 KRW, about +199% upside versus a price of 2,135 KRW (undervalued). Cautious scenario 4,510 KRW, optimistic scenario 9,083 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Pavonine Co Ltd (177830)?
Pavonine Co Ltd reported trailing-twelve-month revenue of about 134B KRW (latest available figure, as of Nov 5, 2026).
Does Pavonine Co Ltd pay a dividend?
Pavonine Co Ltd currently shows a dividend yield of 3.75% relative to its recent price (as of Nov 5, 2026).
How much is the dividend of Pavonine Co Ltd (177830) and when is the ex-dividend date?
Pavonine Co Ltd pays a dividend of 80.00 KRW per share a year, a dividend yield of 3.7%. The last ex-dividend date was Dec 29, 2025. Free cash flow covers the dividend 2.39 times. Our assessment: Cash covered. The dividend is fully funded by free cash flow. The payout ratio on earnings is not available for this company.
What growth is priced into Pavonine Co Ltd (177830)?
For today's price to be fair in a discounted-cash-flow model, Pavonine Co Ltd would have to grow free cash flow by +14.8 % per year for five years (discount rate 8.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -1.3 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of 177830 use?
Our models discount Pavonine Co Ltd at 8.9 %: a base by market capitalisation (nano), damped by beta 0.26, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Pavonine Co Ltd that is +14.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.9 %) and the same formula as our fair value.
How much growth has Pavonine Co Ltd (177830) delivered so far?
Over the past 5 years revenue at Pavonine Co Ltd grew -1.3 % a year. The price currently implies free-cash-flow growth of +14.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Pavonine Co Ltd (177830) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into Pavonine Co Ltd (+14.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Pavonine Co Ltd (177830)?
The free-cash-flow yield on the price is 8.63 %: that much free cash flow Pavonine Co Ltd produces per unit of market value. When it exceeds the discount rate of our models (8.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Pavonine Co Ltd (177830)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Pavonine Co Ltd it is 6,378 KRW per share (as of Nov 5, 2026), against a price of 2,135 KRW. It is the blended result of 12 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Pavonine Co Ltd stock overvalued or undervalued in 2026?
As of Nov 5, 2026, 177830 trades below its calculated fair value: price 2,135 KRW, fair value 6,378 KRW, a gap of about +199% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 177830?
No. The price is what the market pays today (2,135 KRW); the fair value is what the company's own numbers justify (6,378 KRW). For Pavonine Co Ltd the two are 4,243 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Pavonine Co Ltd worth?
The market values Pavonine Co Ltd at about 24.3B KRW (market capitalisation, as of Nov 5, 2026). Per share that is 2,135 KRW; our models calculate a fair value of 6,378 KRW per share.
What do the bullish and bearish scenarios say about 177830?
Our models span a range for Pavonine Co Ltd: cautious scenario 4,510 KRW, base 6,378 KRW, optimistic 9,083 KRW per share (as of Nov 5, 2026, price 2,135 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Pavonine Co Ltd (177830)?
Balance-sheet figures for Pavonine Co Ltd (as of Nov 5, 2026): return on equity −5.8%, debt of 0.05 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is 177830 from its 52-week high?
Pavonine Co Ltd trades at 2,135 KRW, about 31% below its 52-week high of 3,095 KRW and 5% above the low of 2,040 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 6,378 KRW is for.
Which stocks are comparable to Pavonine Co Ltd?
From the same area (Technology) we also value Amphenol Corporation, Hon Hai Precision Industry Co, Corning Incorporated, Delta Electronics, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Pavonine Co Ltd stock attractive at the current price?
The data as of Nov 5, 2026: price 2,135 KRW, calculated fair value 6,378 KRW (+199%), Quality Score 42/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 177830 calculated?
We run Pavonine Co Ltd through 12 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of 6,378 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Pavonine Co Ltd currently trades 67% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Pavonine Co Ltd (177830)?
The closing price on Nov 6, 2026 was 2,135 KRW. Our model-based fair value is 6,378 KRW, about +199% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Pavonine Co Ltd right now?
The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (4,510 KRW). The market is more pessimistic than our downside scenario. A fairly wide model range (4,510 KRW to 9,083 KRW) leaves room in how you read the outcome.
Key figures of Pavonine Co Ltd
How large is the market capitalisation of Pavonine Co Ltd (177830)?
The market capitalisation of Pavonine Co Ltd is 24.3B KRW (≈ $17.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Pavonine Co Ltd (177830)?
The price-to-sales ratio of Pavonine Co Ltd is 0.17 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Pavonine Co Ltd (177830)?
Earnings per share at Pavonine Co Ltd are −354.48 KRW. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Pavonine Co Ltd (177830)?
The dividend yield of Pavonine Co Ltd is 3.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Pavonine Co Ltd (177830)?
The net margin of Pavonine Co Ltd is −2.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Pavonine Co Ltd (177830)?
The return on equity (ROE) of Pavonine Co Ltd is −5.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Pavonine Co Ltd (177830)?
On an EBIT basis the return on assets of Pavonine Co Ltd is 4.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Pavonine Co Ltd (177830)?
The operating margin of Pavonine Co Ltd is 0.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Pavonine Co Ltd (177830)?
Revenue at Pavonine Co Ltd is growing +14.0% versus a year earlier (3y avg +3.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Pavonine Co Ltd (177830)?
Earnings per share at Pavonine Co Ltd are growing −58.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Pavonine Co Ltd (177830) carry?
The net debt of Pavonine Co Ltd is 45.0B KRW (fiscal year 2025, ≈ 21.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Pavonine Co Ltd in the live analysis
One click puts Pavonine Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 5, 2026